Morphic forms of a mutant braf degrader and methods of manufacture thereof
US-2025289827-A1 · Sep 18, 2025 · US
This page is not indexed by search engines while we improve data quality.
Pollock Roy Macfarlane patents
Pollock Roy Macfarlane is listed as an inventor on 9 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Pollock Roy Macfarlane |
| Total patents | 9 |
| First publication | Feb 18, 2016 |
| Latest publication | Sep 18, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Combination therapy for treating cancer
US-2020030355-A1 · Jan 30, 2020 · US
Combination therapy for treating cancer
US-10525074-B2 · Jan 7, 2020 · US
Combination therapy for treating cancer
US-2019083521-A1 · Mar 21, 2019 · US
Combination therapy for treating cancer
US-2018028552-A1 · Feb 1, 2018 · US
Combination therapy for treating cancer
US-2017232030-A1 · Aug 17, 2017 · US
Combination therapy for treating cancer
US-2017080010-A1 · Mar 23, 2017 · US
Combination therapy for treating cancer
US-9446064-B2 · Sep 20, 2016 · US
Combination therapy for treating cancer
US-2016045531-A1 · Feb 18, 2016 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Epizyme Inc | 8 |
| Celgene Corp | 3 |
| C4 Therapeutics Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/7068 | 8 |
| A61K31/706 | 8 |
| A61K31/7076 | 8 |
| A61K31/136 | 7 |
| A61K31/704 | 7 |